Global Immunoaffinity Chromatography Market Size, Forecast, and Trend Highlights Over 2025-2037
Immunoaffinity Chromatography Market size was valued at USD 651.4 million in 2024 and is projected to reach USD 1.6 billion by the end of 2037, rising at a CAGR of 8.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of immunoaffinity chromatography is estimated at USD 702.5 billion.
The market is amplifying at a rapid pace owing to the accelerated demand for immunoaffinity chromatography in biopharmaceutical purification, food safety testing, and clinical diagnostics. This expanded demand is due to the rising burden of cancer, autoimmune disorders, and infectious diseases that necessitate biologics such as monoclonal antibodies, vaccines, and gene therapies. In this regard, the WHO report published in 2023 states that more than 18 million new cases are being diagnosed annually, out of which 72% of biologic development relies on IAC for purification. Besides, the U.S. FDA notes that above 80% of approved mAbs use protein A/G-based IAC, boosting the upliftment in the immunoaffinity chromatography market.
According to the U.S. International Trade Commission data, in 2024, the supply chain of IAC products extensively relies on China and India, supplying approximately 45% of agarose and sepharose resins. Simultaneously, the U.S. and Germany are dominating in terms of high-value resin and column manufacturing. Furthermore, the U.S. Bureau of Labor Statistics, in 2024, notes that the producer price index for IAC resins witnessed a 4.5% year-over-year increase 2024, meanwhile the consumer price index for IAC-based diagnostics witnessed a 4.2% annual rise. This is the evidence for a heightened biopharma demand, resulting in substantial growth of the market.
